Viral Molecules as Immunomodulators with T Lymphocyte Effect
Premier Journal of Immunology · 2024
DOI: 10.70389/pji.100002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Premier Journal of Immunology, 2024. Verfasst von Kee Whun Leo Dan Avila. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The cellular immune response, involving the participation of helper, cytotoxic, and regulatory T lymphocytes, is a determining factor for viral infections. During host and viral coevolution, both parties developed strategies to overcome the other. Among these strategies, viruses encode various proteins to evade specific essential immune response functions, such as T lymphocyte differentiation (Th1/Th2, Th17/Treg). Owing to this evolutionary race, it is possible to identify and test for the therapeutic potential of viral proteins that modulate T lymphocyte effector functions. This work compiles information concerning viral proteins and their pharmacologic potential over T lymphocyte effector functions, focusing on those coded by the hepatitis C virus and the human immunodeficiency virus.
Zitieren
APA
Avila, K. W. L. D. (2024). Viral Molecules as Immunomodulators with T Lymphocyte Effect. Premier Journal of Immunology. https://doi.org/10.70389/pji.100002
Vancouver
Avila KWLD. Viral Molecules as Immunomodulators with T Lymphocyte Effect. Premier Journal of Immunology. 2024. doi:10.70389/pji.100002
BibTeX
@article{Avila2024,
author = {Avila, Kee Whun Leo Dan},
title = {Viral Molecules as Immunomodulators with T Lymphocyte Effect},
journal = {Premier Journal of Immunology},
year = {2024},
doi = {10.70389/pji.100002}
}
EUVIMED